Literature DB >> 21263930

Update on AIDS for the family physician.

M B Garvey.   

Abstract

Infection with Human Immunodeficiency Virus-I (HIV-I) results in a wide spectrum of clinical disease. Many patients remain clinically well, although they may be infectious to others. These patients may, however, suffer from the psychological effects of knowing they have been infected with the virus. Others may develop symptoms, and many develop fatal opportunistic infections and malignant disease. The primary-care physician must be able to educate, to alleviate fear and misunderstanding, and to provide optimal medical and palliative care.

Entities:  

Year:  1987        PMID: 21263930      PMCID: PMC2218533     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  10 in total

Review 1.  Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome.

Authors:  W A Blattner; R J Biggar; S H Weiss; M Melbye; J J Goedert
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

2.  Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome.

Authors:  D E Lewis; J M Puck; G F Babcock; R R Rich
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

3.  Transplacental transmission of HTLV-III virus.

Authors:  N Lapointe; J Michaud; D Pekovic; J P Chausseau; J M Dupuy
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

4.  Human T-lymphotropic virus type III in high-risk, antibody-negative homosexual men.

Authors:  K H Mayer; A M Stoddard; J McCusker; D Ayotte; R Ferriani; J E Groopman
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

5.  Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.

Authors:  J J Goedert; M G Sarngadharan; R J Biggar; S H Weiss; D M Winn; R J Grossman; M H Greene; A J Bodner; D L Mann; D M Strong
Journal:  Lancet       Date:  1984-09-29       Impact factor: 79.321

6.  Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence.

Authors:  D P Stites; C H Casavant; T M McHugh; A R Moss; S L Beal; J L Ziegler; A M Saunders; N L Warner
Journal:  Clin Immunol Immunopathol       Date:  1986-02

7.  Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy.

Authors:  J K Nicholson; J S McDougal; T J Spira; G D Cross; B M Jones; E L Reinherz
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  The epidemiology of AIDS: current status and future prospects.

Authors:  J W Curran; W M Morgan; A M Hardy; H W Jaffe; W W Darrow; W R Dowdle
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

Review 9.  Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Clinical, biological, and molecular features.

Authors:  J A Levy; L S Kaminsky; W J Morrow; K Steimer; P Luciw; D Dina; J Hoxie; L Oshiro
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

  10 in total
  2 in total

1.  A Critical Look at HIV-Antibody Tests: 1. How Accurate Are They?

Authors:  J W Frank; V Goel; B J Harvey; R A Coates; V Schiralli
Journal:  Can Fam Physician       Date:  1987-09       Impact factor: 3.275

2.  A Critical Look at HIV-Antibody Tests: 2. Benefits, Risks and Clinical Use.

Authors:  J W Frank; R A Coates; B J Harvey; V Goel; V Schiralli
Journal:  Can Fam Physician       Date:  1987-10       Impact factor: 3.275

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.